The BRC has directly co-funded 4 projects through the most recent round of the Imperial Confidence-in-Concept funding scheme. These projects are;
G Mylonas, In vivo validation of an inflatable robot for endoscopic tumour dissection (£73,641)
V Terzidou, Circulating miRNAs for the prediction of women at risk of preterm delivery (£79,925)
A Porter, Targeted zinc oxide nanowires as theranostics for triple negative breast cancer (£74,441)
M Levin, Development and validation of a 2 gene RNA test to detect bacterial infection (£80,262)
Based on an £800,000 MRC ‘Confidence in Concept’ award to the College to ‘pump–prime’ the translation of novel therapeutics, devices and diagnostics, and together with support from the BRC, the NIHR BRC at the Royal Marsden and Institute of Cancer Research, Chelsea & Westminster Hospital NHS Foundation Trust and the Imperial College Wellcome Trust Institutional Strategic Support Fund (ISSF), these schemes have created a project-managed fund in excess of £1.3M to identify early targets and technologies, not currently being developed, within the Faculties of Medicine, Natural Sciences and Engineering, to enter into the drug, devices and diagnostics development pathway.